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Abstract: Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism has been associated
with increased susceptibility to develop mood disorders and recently it has been also linked with
cardiovascular disease (CVD). Interestingly, stressful conditions unveil the anxious/depressive-like
behavioral phenotype in heterozygous BDNFVal66Met (BDNFVal/Met) mice, suggesting an important
relationship in terms of gene-environment interaction (GxE). However, the interplay between stress
and BDNFVal/Met in relation to CVD is completely unknown. Here, we showed that BDNFVal/Met
mice display a greater propensity to arterial thrombosis than wild type BDNFVal/Val mice after 7 days
of restraint stress (RS). RS markedly increased the number of leukocytes and platelets, and induced
hyper-responsive platelets as showed by increased circulating platelet/leukocyte aggregates and
enhanced expression of P-selectin and GPIIbIIIa in heterozygous mutant mice. In addition, stressed
BDNFVal/Met mice had a greater number of large and reticulated platelets but comparable number and
maturation profile of bone marrow megakaryocytes compared to BDNFVal/Val mice. Interestingly, RS
led to a significant reduction of BDNF expression accompanied by an increased activity of tissue factor
in the aorta of both BDNFVal/Val and BDNFVal/Met mice. In conclusion, we provide evidence that
sub-chronic stress unveils prothrombotic phenotype in heterozygous BDNF Val66Met mice affecting
both the number and functionality of blood circulating cells, and the expression of key thrombotic
molecules in aorta. Human studies will be crucial to understand whether this GxE interaction need
to be taken into account in risk stratification of coronary artery disease (CAD) patients.
Keywords: BDNF Val66Met; thrombosis; sub-chronic stress
1. Introduction
Increasing evidence suggests that environmental stressors, both physical and psychosocial, affect
not only the onset and progression of central nervous system (CNS) disorders but also contribute to
increase risk, incidence, and severity of cardiovascular disease (CVD) and the response to therapy [1].
The hyperactivation of the hypothalamic–pituitary–adrenal (HPA) axis and stimulation of the
sympathetic adrenomedullary system under stressful conditions lead to release of cortisol and
catecholamines in the circulatory system [2]. These stress hormones play a key function in the
modulation of acute stress adaptation but are responsible of pathological dysregulation when stress
exposure persists. In the CNS, they affect the expression of different genes and molecules involved in
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brain plasticity such as neurotrophins [3]. Moreover, in the periphery they stimulate megakaryo- and
thrombo-poiesis, induce platelet activation [4,5] and endothelial dysfunction, enhance coagulation
pathway activation and reduce fibrinolysis [6] predisposing to onset and progression of CVD [7] and
arterial thrombosis [8]. However, stressors do not affect everyone in the same way. Some individuals
are more susceptible and express inappropriate pathological responses to stressors; in contrast, others,
often called resilient individuals, perceive adversity minimally and develop adaptive physiological
and psychological responses [9,10]. In this context, genetic and epigenetic alterations may influence
vulnerability or resiliency to stressor(s), predisposing to or protecting individuals with different
diseases, including CNS disorders and CVD [11,12].
Brain-derived neurotrophic factor (BDNF), a neurotrophin involved in neural development [13]
and adult brain plasticity [14], has been associated with stress response, depression and anxiety [3,15].
Indeed, BDNF regulates many functions carried out by the HPA axis [16], and the expression of BDNF
is dramatically affected under stressful conditions [17,18].
Interestingly, the BDNF Val66Met single nucleotide polymorphism (SNP), which reduces the
activity-dependent release of BDNF and affects protein and mRNA levels [19–22], has been associated
with an increased susceptibility to develop cognitive and psychiatric disorders [23,24].
As other gene polymorphisms related to mood disorders [12], this SNP has been recently
associated with CVD [25,26]. In particular, BDNF Val66Met polymorphism is associated to propensity
for arterial thrombosis in a cohort of patients with acute myocardial infarction [27]. Consistent with
these human data, homozygous BDNFMet/Met mice display a prothrombotic phenotype with alterations
in coagulation pathways and platelet activation [27].
The emerging hypothesis that genetic alterations predisposes individuals to vulnerability under
stressful conditions is well supported by the results that heterozygous BDNF Val66Met mice display
anxiety- and depression-like behavior phenotypes only after exposure to a paradigm of sub-chronic
stress [28].
However, few studies have examined the interaction of gene-environment (GxE) in CVD [12].
In particular, evidence related to the interaction between BDNFVal/Met and stress in the onset of CVD is
not available. In this study, taking advantage of the BDNF Val66Met knock-in mouse model, we have
investigated the response of BDNFVal/Met mice to stress in relation to arterial thrombosis.
2. Results
2.1. Sub-Chronic Restraint Stress (RS) Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis and
Altered Body Weight
To evaluate whether 7 days of sub-chronic restraint stress (RS) induced a different HPA axis
response in BDNFVal/Val and BDNFVal/Met mice, we measured the weight of adrenal glands, as a key
step of HPA axis activation.
Adrenal gland weight was greater in both BDNFVal/Val and BDNFVal/Met stressed mice compared
to controls and no differences were found between the genotypes, suggesting a comparable level of
stress-response (Figure 1A).
Interestingly, while the weight of BDNFVal/Val stressed mice decreased progressively along 7 days
of RS, the weight of BDNFVal/Met mice decreased during the first 4 days of RS and returned to basal
levels during the following days (Figure 1B).
2.2. RS Predisposed BDNFVal/Met Mice to Thrombosis
To understand whether the interaction between stress and BDNF polymorphism resulted
in a prothrombotic phenotype, we investigated the effect of sub-chronic RS in BDNFVal/Val and
BDNFVal/Met mice focusing on arterial thrombus formation in vivo after topical application of FeCl3 to
exposed carotid.
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RS reduced about 70% of the blood flow in BDNFVal/Met mice after 4 min from FeCl3 application,
whether the blood flow of BDNFVal/Val stressed mice was only slightly affected (Figure 2A). Similarly,
a partial occlusion of carotid artery was observed in the BDNFVal/Val and BDNFVal/Met not-stressed
(CTR) mice without reaching a stable occlusion (Figure 2A). In line with these data, total occlusion
(flow reduction >90%) was reached only in stressed BDNFVal/Met mice after an average time of 20 min
(Figure 2B).
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Figure 1. Effect of sub-chronic stress on BDNFVal/Val and BDNFVal/Met mice. Sub-chronic stress was
induced by restraint stress (RS) treatment for 7 days, 2 h/day. (A) Adrenal gland weight to body
weight ratio (B) Delta (∆) body weight of mice at day 4 and day 8 of stressed (RS) and not stressed
(CTR) BDNFVal/Val and BDNFVal/Met mice. Data are expressed as mean ± SEM. n = 8 mice/group.
Two-way ANOVA and three-way ANOVA with repeated measures followed by Bonferroni post
hoc analysis, p values were obtained by using log-transformed variables. * p < 0.05, ** p < 0.01,
**** p < 0.005 BDNFVal/Val (CTR) vs. BDNFVal/Val stressed (RS) mice, ◦◦◦ p < 0.005 BDNFVal/Met (CTR)
vs. BDNFVal/Met stressed (RS) mice and §§§§ p < 0.00015 BDNFVal/Val stressed (RS) vs. BDNFVal/Met
stressed (RS) ice. For each box-plot, the center line illustrates the median and box limits indicate the
25th and 75th percentiles.
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Figure 2. Effect of restraint stress on arterial thrombosis in BDNFVal/Val and BDNFVal/Met mice.
Arterial thrombosis was induced by topical application of FeCl3 to carotid artery in mice. (A) Blood
flow in the carotid arteries of tressed (RS) and not stressed (CTR) BDNFVal/Val and BDNFVal/Met
mice gr ups. n = 6 mice/grou . Data shown are mean ± SEM. Th e -way ANOVA with repeated
m asures follow d by Bonferroni post hoc analysis, p values were obtaine by using log-transformed
variables. (B) Kapl n-Meier curv representing percentage of mice without occlusion through
time. = 6 mice/group. p values were obtained by a alysing Kaplan-Meier curves by Log-Rank
tests. **** p < 0.001.
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Overall, these data show that heterozygous Met allele per se is not sufficient to predispose to
thrombosis and that the sub-chronic stressful condition triggers the pro-thrombotic phenotype of
BDNFVal/Met mice.
2.3. RS Increased Circulating Blood Cell Number and Platelet Activation State
In our experimental setting, there was a main genotype effect between BDNFVal/Val and
BDNFVal/Met mice in terms of circulating blood cells and platelet function.
RS increased the number of leukocytes (Figure 3A) and platelets (Figure 3B), as well as the
percentage of reticulated platelets (Figure 3C) in both BDNFVal/Val and BDNFVal/Met mice compared
to not stressed mice (CTR). Remarkably, the effect of RS was greater in BDNFVal/Met platelets than in
BDNFVal/Val (Figure 3B,C).
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Figure 3. Circulating blood cell numbers are increased by restraint stress. (A) Numbers of circulating
leukocytes, (B) platelets were counted, and (C) the percentage of reticulated platelets were analysed
by flow cytometry in stressed (RS) and not stressed (CTR) BDNFVa /Val and BDNFVal/Met mice.
n = 6 mice/group. Two-way ANOVA followed by Bonferroni post hoc analysis, p values were obtained
by using log-transformed variables. * p < 0.05, ** p < 0.01 and **** p < 0.001. For each box-plot, the center
line illustrates the edian and box limits indicate the 25th and 75th percentiles.
In addition, while platelets from BDNFVal/Val stressed mice displayed similar activation of integrin
αIIbβ3 (GPIIbIIIa) (Figure 4A) and expression of P-selectin (Figure 4B) in response to thrombin (THR)
and ADP compared to mice not exposed to RS, platelets fr m BDNFVal/Met str ssed mic h w d a
marked hyper-re ctivity (Figure 4A,B).
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Figure 4. Effect of restraint stress on platelet activation in BDNFVal/Val and BDNFVal/Met mice.
Flow cytometry analyses of: (A) GPIIbIIIa activation (JON/A-PE antibody); (B) P-selectin expression in
washed platelets at basal condition or after exposure to ADP (5 µM) or thrombin (THR 0.05 U/mL); and
percentage of (C) platelet/leukocytes in whole blood isolated from stressed (RS) and not stressed (CTR)
BDNFVal/V l and BDNFVal/Met mice. n = 6 mice/group. Two-way ANOVA followed by Bonferroni
post hoc analysis, p values were obtained by using log-transformed variables. * p < 0.05, ** p < 0.01 and
*** p < 0.005. For each box-plot, the center line illustrates the median and box limits indicate the 25th
and 75th percentiles.
Int. J. Mol. Sci. 2018, 19, 3235 5 of 13
Finally, RS enhanced the formation of the platelet/leukocyte aggregates in response to ADP in
both BDNFVal/Val and BDNFVal/Met mice. However, the percentage of platelet/leukocyte aggregates
increased more markedly in stressed BDNFVal/Met mice compared to both BDNFVal/Met mice not
exposed to RS and BDNFVal/Val mice exposed to RS (Figure 4C).
2.4. RS Increased Bone-Marrow Megakaryocytes Number without Affecting Their Maturation State
To understand if the change in platelet number detected under stressful conditions was the
consequence of an alteration of megakaryopoiesis process, immunocytochemistry analysis of the femur
bone marrow was carried out.
Analysis of femur bone marrow sections evidenced that RS enhanced the number of
megakaryocytes (MKs) in both BDNFVal/Val and BDNFVal/Met mice (Figure 5A,B). Nevertheless, MKs
displayed similar dimensions (Figure 5C) and nuclear complexity (Figure 5D) with comparable
percentage of mononucleated, binucleated, or polynucleated cells among all the analyzed groups.
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It is well known that stress modulates tissue-factor (TF) activity [8], a key regulator of thrombus 
formation. Therefore, we examined expression and activity of TF in carotid artery tissues. 
Interestingly, while RS increased the activity of TF in carotid tissue (Figure 6A) of both 
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Figure 5. Effect of restraint stress on bone-marrow megakaryocytes. (A) Hematoxylin and Eosin (H&E)
staining of bone marrow from stressed (RS) and not stressed (CTR) BDNFVal/Val and BDNFVal/Met
mice. Asterisks indicate MKs. (B) Quantification of panel (A) expressed as megakaryocytes per
field (40× magnification). Analysis of (C) area and of (D) nuclear complexity in megakaryocytes.
n = 8 mice/group. Two-way ANOVA followed by Bonferroni post hoc analysis, p values were obtained
by using log-transformed variables. ** p < 0.01 and **** p < 0.001. For each box-plot, the center line
illustrates the median and box limits indicate the 25th and 75th percentiles.
2.5. RS Altered the Expression of Tissue Factor and BDNF but Not the Expression of Sirt1
It is well known that stress modulates tissue-factor (TF) activity [8], a key regulator of thrombus
formation. Therefore, we examined expression and activity of TF in carotid artery tissues.
Interestingly, while RS increased the activity of TF in carotid tissue (Figure 6A) of both BDNFVal/Val
and BDNFVal/Met mice, the exposure to this stressful condition enhanced TF mRNA expression only in
Int. J. Mol. Sci. 2018, 19, 3235 6 of 13
BDNFVal/Met mice (Figure 6B). Comparable levels of TF expression and activity were detected in the
control groups (Figure 6A,B).
Then, we measured the expression of Sirt1, an important modulator of TF and arterial
thrombosis [29,30]. However, we did not found significant changes in terms of Sirt1 mRNA expression
in arterial tissues among all the groups analyzed (Figure 6C).
Of note, BDNF expression was comparable in control BDNFVal/Met and BDNFVal/Val mice,
and although RS affected its expression in both genotypes this reduction was higher in BDNFVal/Val
mice (Figure 6D).
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Figure 6. Impact of restraint stress on Tissue Factor, BDNF and Sirt1 expression in arterial tissue.
(A) Tissue Factor (TF) activity and (B) TF, (C) Sirt1, (D) BDNF mRNA levels in arterial tissue of stressed
(RS) and not stressed (CTR) BDNFVal/Val and BDNFVal/Met mice. n = 8 mice/group. Two-way ANOVA
followed by Bonferroni post hoc analysis, p values were obtained by using log-transformed variables.
** p < 0.01, and *** p < 0.005. For each box-plot, the center line illustrates the median and box limits
indicate the 25th and 75th percentiles.
3. Discussion
Starting from the hypothesis that many multifactorial pathologies, including CVD, may result
from the interaction between genes and environmental (GxE) factors and that some genetic variants,
including BDNF Val66Met, are susceptible to stressors [12,15,31], we provide evidence that sub-chronic
stress interacts with BDNF Val66Met polymorphism to unveil prothrombotic phenotype in a murine
model. The major finding of this study is that seven days of RS, already reported to promote
anxiety/depressive-like phenotype in heterozygous BDNF Val66Met (BDNFVal/Met) mice [28], are
sufficient to exacerbate arterial thrombosis in BDNFVal/Met mice and enhance platelet activation and
coagulation pathway.
The dysfunctions in adrenergic and HPA axis observed in Met allele carriers [32] might
explain their propensity to anxiety and depressive related disorder [28] and concomitantly to the
development of a prothrombotic phenotype, observed here. Indeed, it is well known that the
activation of HPA axis under stressful condition promotes dysregulation of both norepinephrine [2] and
coagulation system (e.g., tissue factor and the plasminogen activation inhibitor-1) [33,34], and affects
platelet number [4,5] and functionality [5,8,35–38], triggering the prothrombotic state. In addition,
the significant volumetric reduction of the hippocampus [39] and the hyperactivation of amygdala [40]
detected in humans carrying at least one Met allele and also observed in subjects under stressful
conditions and neuropsychiatric disorders [41,42], support this hypothesis. Indeed, hippocampal
neurons exert an inhibitory effect on the activation of the HPA axis, whereas the activity of the
amygdala exerts a significant excitatory effect on the axis. Interestingly, the increased activity of
amygdala has been recently associated with increased risk of CVD events and with enhanced bone
marrow activity [43]. We show here that seven days of RS are sufficient to enhance the number
of bone marrow MKs, circulating leukocytes and platelets and to induce platelet activation in
BDNFVal/Val mice, according to previously data obtained from both human and animal models [4,5,35].
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These effects disproportionately increased in stressed BDNFVal/Met mice predisposing them to
thrombosis. Interestingly, all the alterations observed here in stressed heterozygotes BDNFVal/Met mice
recapitulate the phenotype observed in non-stressed BDNFMet/Met homozygous mice [27].
Recently, Stämpfli et al. have shown that acute RS, although inducing arterial thrombosis in mice,
did not affect activity and expression of TF, the principal activator of blood coagulation, in the vessel
wall [8]. Here, we provide evidence that in wild type BDNFVal/Val mice sub-chronic RS increases TF
activity without modifying mRNA, suggesting that a protracted stress is able to modulate TF in a
post-transcriptional manner. Remarkably both TF expression and activity were positively modulated
in BDNFVal/Met mice under sub-chronic stress, supporting the hypothesis of BDNF gene vulnerability.
However, sub-chronic stress did not modify the expression of Sirt1, a modulator of TF expression
and of arterial thrombosis, as previously shown in BDNFMet/Met mice [27], in all experimental groups
considered. Further experiments will be performed to understand which pathways are involved in
the modulation of TF induced by protracted stress in order to unveil new possible targets that limit
cardiovascular complications associated with environmental factors.
Interestingly, both BDNF Met allele variant and stressful conditions are associated with lower
expression of BDNF in the central nervous system [28,44]. However, no data are available concerning
the impact of this polymorphism and/or stress in other tissues. We show that BDNF mRNA levels are
only slightly reduced in the arterial tissue of BDNFVal/Met mice compared to BDNFVal/Val. In addition,
although sub-chronic RS induced a decreasing trend in BDNF expression in both BDNFVal/Met and
BDNFVal/Val, the reduction was significant only in BDNFVal/Val suggesting that the reduction of BDNF
in arterial tissue is possible only to a certain threshold level, supporting its fundamental role in the
vascular physiology [45–47].
Finally, our data, showing a weight reduction in stressed BDNFVal/Val mice along the experimental
time, are consistent with a previous study [48]. The weight loss observed during the stress exposure is
potentially due initially to an early decrease in food intake and subsequently to an increased in energy
expenditure and in body temperature [48]. In contrast, in BDNFVal/Met mice we observed a weight loss
only in the first few days of RS, followed by a surprising gain of weight, which returns to basal levels
at the eighth day. This trend might be explained by the critical role of BDNF in the regulation of food
intake and body weight control [49]. Indeed, BDNF is an anorexigenic factor [49], and low levels of
BDNF in hippocampus and dorsal-vagal complex [50] as well as mutation in the BDNF gene [19,51–53]
are associated with hyperphagia, weight gain and obesity. On these premises, we hypothesize that
sub-chronic stress unmasks the hyperphagic phenotype in BDNFVal/Met mice balancing the normal
initial weight loss by enhancing food intake.
4. Materials and Methods
4.1. Mice
All experiments have been performed in adult male BDNFVal/Met mice and littermate BDNFVal/Val
mice (3–4 months old) derived from BDNFVal/Val × BDNFVal/Met crossed parents [19]. All experiments
were approved by the National Ministry of Health-University of Milan Committee and of DGSA
(12/2012). Surgical procedures were performed in mice anesthetized with ketamine chlorhydrate
(75 mg/kg; Intervet, Segrate, Milan, Italy) and medetomidine (1 mg/kg; Virbac, Milan, Italy).
Mice were weighted and sacrificed 24 h after the last session of restraint stress RS. Tissues and
blood were collected and adrenal glands were weighted.
4.2. Restraint Stress (RS) Procedure
Sub-chronic stress was induced by restraint stress (RS) test performed as previously described [28].
Briefly, BDNFVal/Val and BDNFVal/Met mice were divided randomly into stressed (RS) and control
(CTR) groups. RS was performed daily for 2 h for 7 consecutive days, in well ventilated polypropylene
Int. J. Mol. Sci. 2018, 19, 3235 8 of 13
restrainers without access to food and water. At the end of the stress session, mice were returned to
their home cage. CTR mice were handled for 2 min and then returned to home cage.
4.3. Arterial Thrombosis Model
Experimental arterial thrombosis was induced as previously described [54]. Left carotid artery of
anesthetized mice was dissected free and placed in the probe (model 0.7 V, Transonic System, Ithaca,
NY, USA) connected to transonic flowmeter (TransonicT106). After blood flow stabilization (baseline
flow constant for 7 min at least 0.8 mL/s), a 1 × 1 mm strip of filter paper (Whatman N◦1) soaked
with FeCl3 (10% solution; Sigma-Aldrich, Saint Louis, MO, USA) was applied over the carotid artery.
After 3 min, the filter paper was removed, the carotid artery washed with PBS, and the flow recorded
for 30 min. An occlusion was considered to be total and stable when the flow was reduced by >90%
from baseline until the 30 min observation time, with the flow during this period not changing by
more than 1% from baseline per second.
4.4. Whole Blood Counts
Blood was collected into 3.8% sodium citrate (1:10 vol:vol) from anesthetized mice by cardiac
venipuncture, and white blood cells and platelet were counted optically [29].
4.5. Platelet–Leukocyte Aggregate Analysis
Platelet/monocyte and platelet/neutrophil aggregates were analysed as previously described [5].
Briefly, citrated blood was stimulated where indicated with 5 µM ADP for 5 min and red blood
cells were lysed by FACS Lysing solution; samples were stained with the anti-CD45, anti-CD41,
and anti-CD14 or anti-Lys6G and analysed by flow FACS “Novocyte 3000”. A minimum of 5000 events
was collected in the CD14+ or Lys6G+ gate.
4.6. Platelet Studies
Washed platelets (WPs) were obtained from platelet-rich plasma (PRP), isolated following
centrifugation at 100× g for 10 min of citrated blood as previously described [27], with serial
centrifugation and addition of 0.2 mM PGI2 and 0.01 mg/L apyrase. Platelet pellets were resuspended
in HEPES-Tyrode’s buffer (137 mM NaCl, 20 mM HEPES, 5.6 mM glucose, 0.35% bovine serum, 1 mM
MgCl2, 2.7 mM KCl, and 3.3 mM NaH2PO4). 25 µL of WPs (5 × 104/µL in HEPES-Tyrode’s buffer
supplemented with 1 mM CaCl2) was mixed with a saturating concentration of PE-conjugated JON/A
antibody, raised against the activated form of GPIIbIIIa (αIIβIII integrin), or with anti-CD62P and
FITC-conjugated antibody and the mixture reacted with different concentrations of ADP or thrombin
for 15 min at room temperature. The reaction was stopped by 400 µL ice-cold PBS, and samples were
analysed within 30 min. Platelets were identified by forward and side scatter distribution and by
anti-CD41 positivity.
Reticulated platelets were identified by the thiazole orange method [55]: 10 µL of PRP was
incubated with 390 µL of thiazole orange or PBS as control and anti-CD41 at room temperature for
10 min, in the dark. Immediately after incubation, samples were analysed by flow cytometry collecting
10,000 CD41-positive events; the percentage of RP was recorded, and the absolute number of RP was
calculated by multiplying by the platelet count.
4.7. Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR)
Total cellular RNA was isolated from arterial tissue with TRIzol Reagent according to the
manufacturer’s instructions. One µg of RNA was reverse-transcribed using iScript™ cDNA Synthesis
Kit. RT-qPCR was then carried out to detect Tissue Factor (TF), Sirt1, BDNF, and GAPDH used for
normalized. The primers used for mice were: TF: forward 5′-CGGGTGCAGGCATTCCAGAG-3′,
reverse 5′-CTCCGTGGGACAGAGAGGAC-3′; SIRT1: forward 5′-AGCAGGTTGCAGGAATCCAA-3′,
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reverse 5′-CACGAACAGCTTCACAATCAACTT-3′; BDNF: forward 5′-TCGTTCCTTTCGAGTTA
GCC-3′, reverse 5′-TTGGTAAACGGCACAAAAC-3′ and GAPDH: forward 5′-CGTGCCGCCTG
GAGAAACC-3′, reverse 5′-TGGAAGAGTGGGAGTTGCTGTTG-3′. Samples of cDNA were incubated
in 15 µL IQ Supermix containing BDNF, TF, Sirt1 or GADPH primers and fluorescent dye SYBR Green
(Bio-Rad Laboratories, Segrate, Milan, Italy). RT-qPCR was carried out in triplicate for each sample
on the CFX Connect real-time System (Bio-Rad Laboratories, Segrate, Milan, Italy). Gene expression
was analyzed using parameters available in CFX Manager Software 3.1 (Bio-Rad Laboratories, Segrate,
Milan, Italy).
4.8. Measurement of TF Activity in Aortic Tissue
Before assay, samples were lysed with 15 mM n-Octyl-B-D-glucopyranoside lysis buffer at 37 ◦C
for 10 min, sonicated at 20 kHz for 20 s and diluted with 25 mM HEPES saline. The total protein
concentrations of carotid artery homogenates was determined using the Bradford method. 40 µL of
carotid artery homogenate (1.25 µg/uL), or vehicle were mixed with 40 µL citrated pooled wild-type
mouse plasma and 40 µL CaCl2 (final concentration 5 mM), and procoagulant activity was quantified
by a one-stage plasma recalcification time assay [56]. Clotting times were expressed in relative
units/µg protein based on a standard curve of serially diluted human thromboplastin preparation.
Plasma deficient of Factor VIIa as well as preincubation with specific TF-neutralizing antibody were
used to demonstrate TF dependence of procoagulant activity.
4.9. Bone Marrow Histology and MK Analyses
Immunocytochemistry and analysis of megakaryocytes (MKs) was performed on bone marrow
(BM) as previously described [5]. Tissues were fixed overnight in 4% formalin, embedded in paraffin,
cut at 3 µm, and mounted on polarized slides. BM samples were decalcified in 10% EDTA, pH 8 for
10 days before paraffin embedding. The number and area of MKs were evaluated in hematoxylin and
eosin stained sections by counting 5–7 40×microscopic fields for each tissue sample digitalized by a
Zeiss Axioskop (Carl Zeiss, Milan, Italy) equipped with an intensified charge-coupled device (CCD)
camera system (Photometrics, Tucson, AZ, USA).
4.10. Statistical Analysis
Statistical analyses were performed with GraphPad Prism 7.0 and SAS versus 9.4 software (SASA
Institute, Cary, NC, USA). Data were analyzed by 2-way or 3-way ANOVA with or without repeated
measures for main effects of treatment and time or stimuli as reported in every graph, followed by
a Bonferroni post hoc analysis as appropriate. Kaplan-Meier curves were analyzed by Log-Rank
tests. Having a skewed distribution, the variables were included into the analyses after logarithmic
transformation. Values of p < 0.05 were considered statistically significant. Data are expressed as
mean ± SEM. For each box-plot, the center line illustrates the median, and box limits indicate the 25th
and 75th percentiles.
5. Conclusions
In conclusion, we provide evidence that sub-chronic stress unveils a prothrombotic phenotype
in heterozygous BDNFVal/Met mice affecting the number and functionality of blood circulating cells,
and the expression of key thrombotic molecules in arterial tissue. Human studies will be crucial
to understand whether this gene-environment interaction needs to be taken into account in the
risk stratification of coronary artery disease (CAD) patients. The identification of patients carrying
“vulnerable genes” will be useful to identify new strategies to prevent and treat CAD.
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